Physician profile

Muhammad Hammad Malik

Diagnostic Radiology · Framingham, MA

NPI 1255062089

$2,425.40

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,857.11
Food and Beverage$415.93

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $2,056.71 2024 Indigo System
E.R. Squibb & Sons, L.L.C. $119.12 2022-2023 Camzyos
Stryker Corporation $86.27 2024 N/A, Ortholoc 2 Lapifuse
Inari Medical, INC. $69.14 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Medtronic, INC. $64.20 2022
Seagen INC. $29.96 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Muhammad Hammad Malik

$2,425.40

in general payments reported 2019-2025

Years
2022-2024
Top company
Penumbra, INC.

https://glasscript.com/doctor/11333085/muhammad-hammad-malik

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.